1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	NF-kappa	NF-kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	interleukin	interleukin	_	_	_	_	_	_	_
7	2	2	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	blood	blood	_	_	_	_	_	_	_
11	monocytes	monocyte	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	report	report	_	_	_	_	_	_	_
3	here	here	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	interleukin	interleukin	_	_	_	_	_	_	_
6	2	2	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	IL-2	il-2	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	acts	act	_	_	_	_	_	_	_
11	on	on	_	_	_	_	_	_	_
12	human	human	_	_	_	_	_	_	_
13	blood	blood	_	_	_	_	_	_	_
14	monocytes	monocyte	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	enhancing	enhance	_	_	_	_	_	_	_
17	binding	binding	_	_	_	_	_	_	_
18	activity	activity	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	transcription	transcription	_	_	_	_	_	_	_
22	factor	factor	_	_	_	_	_	_	_
23	NF-kappa	NF-kappa	_	_	_	_	_	_	_
24	B	B	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	its	its	_	_	_	_	_	_	_
27	consensus	consensus	_	_	_	_	_	_	_
28	sequence	sequence	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	5	5	_	_	_	_	_	_	_
32	â€™	'	_	_	_	_	_	_	_
33	regulatory	regulatory	_	_	_	_	_	_	_
34	enhancer	enhancer	_	_	_	_	_	_	_
35	region	region	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	the	the	_	_	_	_	_	_	_
38	IL-2	il-2	_	_	_	_	_	_	_
39	receptor	receptor	_	_	_	_	_	_	_
40	alpha	alpha	_	_	_	_	_	_	_
41	chain	chain	_	_	_	_	_	_	_
42	(	(	_	_	_	_	_	_	_
43	p55	p55	_	_	_	_	_	_	_
44	)	)	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	Similarly	similarly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	IL-2	IL-2	_	_	_	_	_	_	_
4	activates	activate	_	_	_	_	_	_	_
5	NF-kappa	NF-kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	monocytic	monocytic	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	line	line	_	_	_	_	_	_	_
13	U	U	_	_	_	_	_	_	_
14	937	937	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	but	but	_	_	_	_	_	_	_
17	not	not	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	resting	rest	_	_	_	_	_	_	_
20	human	human	_	_	_	_	_	_	_
21	T-cells	t-cell	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	effect	effect	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	detectable	detectable	_	_	_	_	_	_	_
5	within	within	_	_	_	_	_	_	_
6	15	15	_	_	_	_	_	_	_
7	min	min	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	peaks	peak	_	_	_	_	_	_	_
10	1	1	_	_	_	_	_	_	_
11	h	h	_	_	_	_	_	_	_
12	after	after	_	_	_	_	_	_	_
13	exposure	exposure	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	IL-2	il-2	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Enhanced	enhance	_	_	_	_	_	_	_
2	NF-kappa	NF-kappa	_	_	_	_	_	_	_
3	B	B	_	_	_	_	_	_	_
4	binding	binding	_	_	_	_	_	_	_
5	activity	activity	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	followed	follow	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	functional	functional	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	inducibility	inducibility	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	IL-2	il-2	_	_	_	_	_	_	_
17	receptor	receptor	_	_	_	_	_	_	_
18	alpha	alpha	_	_	_	_	_	_	_
19	chain	chain	_	_	_	_	_	_	_
20	is	be	_	_	_	_	_	_	_
21	mediated	mediate	_	_	_	_	_	_	_
22	by	by	_	_	_	_	_	_	_
23	enhanced	enhance	_	_	_	_	_	_	_
24	NF-kappa	NF-kappa	_	_	_	_	_	_	_
25	B	B	_	_	_	_	_	_	_
26	binding	binding	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	that	that	_	_	_	_	_	_	_
29	a	a	_	_	_	_	_	_	_
30	heterologous	heterologous	_	_	_	_	_	_	_
31	promoter	promoter	_	_	_	_	_	_	_
32	containing	contain	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	NF-kappa	NF-kappa	_	_	_	_	_	_	_
35	B	B	_	_	_	_	_	_	_
36	consensus	consensus	_	_	_	_	_	_	_
37	sequence	sequence	_	_	_	_	_	_	_
38	(	(	_	_	_	_	_	_	_
39	-291	-291	_	_	_	_	_	_	_
40	to	to	_	_	_	_	_	_	_
41	-245	-245	_	_	_	_	_	_	_
42	)	)	_	_	_	_	_	_	_
43	of	of	_	_	_	_	_	_	_
44	the	the	_	_	_	_	_	_	_
45	IL-2	il-2	_	_	_	_	_	_	_
46	receptor	receptor	_	_	_	_	_	_	_
47	alpha	alpha	_	_	_	_	_	_	_
48	chain	chain	_	_	_	_	_	_	_
49	gene	gene	_	_	_	_	_	_	_
50	is	be	_	_	_	_	_	_	_
51	activated	activate	_	_	_	_	_	_	_
52	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	IL-2	il-2	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	capable	capable	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	increasing	increase	_	_	_	_	_	_	_
9	transcript	transcript	_	_	_	_	_	_	_
10	levels	level	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	p50	p50	_	_	_	_	_	_	_
14	gene	gene	_	_	_	_	_	_	_
15	coding	cod	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	p50	p50	_	_	_	_	_	_	_
19	subunit	subunit	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	NF-kappa	NF-kappa	_	_	_	_	_	_	_
23	B	B	_	_	_	_	_	_	_
24	transcription	transcription	_	_	_	_	_	_	_
25	factor	factor	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	whereas	whereas	_	_	_	_	_	_	_
28	mRNA	mrna	_	_	_	_	_	_	_
29	levels	level	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	p65	p65	_	_	_	_	_	_	_
33	NF-kappa	NF-kappa	_	_	_	_	_	_	_
34	B	B	_	_	_	_	_	_	_
35	gene	gene	_	_	_	_	_	_	_
36	remained	remain	_	_	_	_	_	_	_
37	unchanged	unchanged	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

